 Sonoma Pharmaceuticals NASDAQ: SNOA shares are trading higher on Friday after the company announced a partnership with Gabriel Science for dental markets. Sonoma is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. 